ULTIMA HORA
	
            
            COVID 19 SOLICITUD AYUDA ESTUDIO EPIDEMIOLOGICO
            
    Queridos amigos, familia, colegas
 
En este difícil momento del brote de COVID-19, sabemos que muchas personas están sufriendo emocional y mentalmente. Por ello, la Fundación Cerebro y Mente está llevando a cabo un estudio para determinar cómo este brote afecta a los síntomas de ansiedad y depresión en la población española (los infectados, los no infectados o los no probados). Un mes después de que se hayan levantado las restricciones de aislamiento, volveremos a evaluar estos síntomas, para ver si han mejorado. 
 
Les invitamos a ayudarnos con este importante estudio. Es importante que entendamos cómo la pandemia y el aislamiento social influyen en la salud mental. Queremos ver qué factores ayudan a las personas a sobrellevar mejor la situación y qué factores hacen que las personas sean más susceptibles de desarrollar ansiedad y síntomas depresivos. Esta información nos ayudará a desarrollar estrategias de tratamiento para después del COVID-19. También nos proporcionará pautas para la atención de la salud mental durante futuras pandemias.
 
Por favor, envíen el enlace al mayor número de personas posible y mantengámonos unidos y ayudemos a mejorar la salud mental en España.
 
            
FORMULARIO
            
Gracias
Últimas Publicaciones
Próximo curso
Madrid 11 y 12 de Noviembre de 2019
IX Curso Teórico-Práctico Intensivo de actualización en Terapia Electroconvulsiva
Más informaciónÚltimo congreso
Fecha 20-21 Junio 2014
Relevance of Staging Psychotic disorders as a Paradigm-shift for understanding disease progression and stage-dependent treatment.
Más informaciónPublicaciones
Vol.10 Staging Neuropsychiatric Disorders: Implications for Etiopathogenesis and Treatment
|  | June 2013  | Más información | 
Also found within the publication, are contributions presented at the meeting held in Mojácar in 2009.
Tabla de contenidos
Part I Clinical Staging in the Pathophysiology of Psychotic and Affective Disorders: Facilitation of Prognosis and Treatment
- Regional Differences in the Action of Antipsychotic Drugs: Implications for  Cognitive Effects in Schizophrenic Patients
 Richard J. Beninger, Tyson W. Baker, Matthew M. Florczynski and Tomek J. Banasikowski
- Staging in Neuropsychiatry: A Heuristic Model for Understanding,  Prevention and Treatment
 Patrick D. McGorry
- Brain Imaging in Early Stages of Psychosis: From the at Risk Mental State to First Episode
 Philip McGuire
- Mechanisms of Illness Progression in the Recurrent Affective Disorders
 Robert M. Post
- Neurocognitive Indicators of Clinical High-Risk States for Psychosis: A  Critical Review of the Evidence
 Ralf Pukrop and Joachim Klosterkötter
- Apathy in Neuropsychiatric Disease: Diagnosis, Pathophysiology, and  Treatment
 Thomas N. Chase
- Staging Bipolar Disorder
 Eduard Vieta, M. Reinares and A.R. Rosa
- Inflammatory Biomarkers and Depression
 Norbert Müller, Aye-Mu Myint and Markus J. Schwarz
- Does Higher Potency of Cannabis Mean Higher Risk for Psychosis?
 Marta Di Forti, Alessandra Paparelli, Paola Casadio and Robin M. Murray
- 5-HT2A Polymorphisms and Negative Symptoms Response to Antipsychotic  Treatment: Evidence of Association in First Episode Psychosis Patients
 Benedicto Crespo-Facorro, Maria Jesús Arranz, Ignacio Mata, Javier Vázquez- Bourgon, Rocío Pérez-Iglesias, Laura Medina-González, José María Pelayo- Terán, Eugenio Carrasco-Marín, José Luis Vázquez-Barquero
- Staging of Cognitive Impairment, Incidence of Dementia, and Mortality  Risk:  Preliminary Results with a Simply Method Based on the Mini  Mental Status Examination
 Antonio Lobo, Raúl López-Antón, Concepción de-La Cámara, Miguel Ángel Quintanilla, Antonio Campayo, Javier Santabarbara, Tirso Ventura, Andrés Martín, Pedro Saz, and Guillermo Marcos
- Circadian Rhythms in the Physiopathology of Depression: A New Opportunity of Therapeutic Approach
 Cecilio Álamo and Francisco López-Muñoz
Part II Staging Perspectives in Neurodevelopmental Aspects of Neuropsychiatry: Agents, Phases and Ages at Expression
- Adolescent Maturation of Cortical Dopamine
 Patricio O´Donnell
- Amyloid-b Precursor Protein Induces Glial Differentiation of Neural  Progenitor Cells by Activation of the IL-6/gp130 Signaling Pathway
 Young-Don Kwak, Elise Dantuma, Stephanie Merchant, Sergey Bushnev and Kiminobu Sugaya
- Stereotypic Progressions in Psychotic Behavior
 Richard M. Kostrzewa, John P. Kostrzewa, Rose Anna Kostrzewa, Florence P. Kostrzewa, Ryszard Brus, Przemyslaw Nowak
- Diabetes Type II: A Risk Factor for Depression–Parkinson–Alzheimer?
 Peter Riederer, Jasmin Bartl, Gerd Laux, Edna Grünblatt
- Progression of Atrophy in Alzheimer’s disease and Related Disorders
 Jennifer L. Whitwell
- Neurodevelopment and Learning in Adolescence: Relevance to Staging
    of psychiatric disorders
 David Sturman and Bita Moghaddam
- Mild Cognitive Impairment: A 5-Year Follow-Up and Imaging Study
 J.A. Lonie, U.G. Kalu, C.E. Sexton, C.E. Mackay, M. Bastin, E. Terriére, R.E. O’Carroll, K.P. Ebmeier
- The Neural Circuitry of Autism
 Aysenil Belger, Kimberly L. H. Carpenter, Gunes Yucel, and Katherine M. Cleary
Part III Epigenetics and Biomarkers in the Staging of Neuropsychiatric Disorders
- Dopamine System Dysregulation by the Ventral Subiculum as the Common
    Pathophysiological Basis for Schizophrenia Psychosis, Psychostimulant  Abuse, and Stress
 Anthony A. Grace
- Persistence of Long-Term Memory Storage: New Insights into its Molecular
    Signatures in the Hippocampus and Related Structures
 Pedro Bekinschtein, Cynthia Katche, Leandro Slipczuk, Carolina Gonzalez, Guido Dorman, Martín Cammarota, Iván Izquierdo, Jorge H. Medina
- Epigenetically Regulated Imprinted Genes and Foetal Programming
 Eric B. Keverne
- Regulation of AMPA Receptor Trafficking in the Nucleus Accumbens
    By Dopamine and Cocaine
 Marina E. Wolf
- Inhibition of Actin Polymerization Prevents Cocaine-induced Changes in  Spine Morphology in the Nucleus Accumbens
 Shigenobu Toda, Haowei Shen, Peter W. Kalivas
- Decision-Making, Behavioral Supervision and Learning: An Executive Role  for the Ventral Premotor Cortex?
 C. Acuña, J.L. Pardo-Vázquez, V. Leborán
- Antipsychotic Induced Changes in Striatal D2 Receptors in Schizophrenia:  in Vivo Evidence from Dopamine Depletion Studies
 Anissa Abi-Dargham, Larry Kegeles, Mark Slifstein and Marc Laruelle
- The ANKK1 Protein Associated with Addictions has Nuclear and Cytoplasmic Localization and Shows a Differential Response of Ala239Thr to Apomorphine
 E. Garrido, T. Palomo, G. Ponce, I. García-Consuegra, M. A. Jiménez-Arriero, and J. Hoenicka
- Synaptic and Nuclear Localizations of the G Protein-Coupled Receptor GPR88
 Renaud Massart, Jorge Diaz, and Pierre Sokoloff
Part IV Staging Neurodegenerative Disorders: Structural, Regional, Biomarker, and Functional Progressions
- Cortical and Sub-Cortical Effects in Primate Models of Cocaine Use:
    Implications for Addiction and the Increased Risk of Psychiatric Illness
 Charles W. Bradberry
- Critical Age Windows for Neurodevelopmental Psychiatric Disorders:
    Evidence from Animal Models
 Eva M. Marco, Simone Macrí, Giovanni Laviola
- Immaturities in Incentive Processing and Executive Function in  Adolescence
 Charles Geier, Aarthi Padmanabhan, and Beatriz Luna
- Alpha-Synucleinopathy and Neuropsychological Symptoms in a Population- Based Cohort of the Elderly
 J. Zaccai, C. Brayne, F.E. Matthews, P.G. Ince
Fundación Cerebro y Mente
 c/ General Oraa, 47 - 1º E 28006 Madrid, España
 
Telf: +34 91 561 1267 Fax: +34 91 564 1817
http://www.cermente.com 
© 2009 Fundación Cerebro y Mente. Todos los derechos reservados.



